New therapy for Dry Maculopathy approved in the USA in February 2023. The treatment is called Pegcetacoplan and is injected inside the eye with intravitreal injections. Pegcetacoplan is the first effective treatment for dry maculopathy, it is a different injection compared to other intravitreal injections used to date only for wet maculopathy. This treatment is […]
The new drug for the treatment of Wet and Diabetic Maculopathy is called Faricimab. It requires less frequent administration than older therapies. Wet maculopathy and diabetic edema are treated with injections of antiVEGF drugs into the eye approximately every 1 or 2 months. The new drug is injected every 4 months. In clinical trials, patients […]
Maculopathy is the degeneration of the macula. The macula is the central part of the retina, the noblest part, the one that allows us to see the objects in front of us, to see details and distinguish colors. The aging of the macula is associated with image distortion and the loss of the ability […]
The new gene therapy for Dry Maculopathy comes from England and has just been presented by the English radio and television broadcaster BBC. Gyroscope Therapeutics has developed a therapy that could halt the progression of dry maculopathy. Today there is no therapy to stop dry maculopathy, if the new therapy proved effective it would be […]
EyeMax is a new opportunity to improve the vision of those suffering from Maculopathy Dr. Badalà is one of the most expert users of this lens. He was interviewed by the scientific journal Ocular Surgery News on the occasion of his presentation at the congress of the European Society of Cataract and Refractive Surgery (ESCRS) […]
The new drug for the treatment of wet or exudative maculopathy is called Brolucizumab. It is produced by the Novartis company which has just announced the results of clinical trials in Vienna on the occasion of the Euretina congress from 20 to 23 September 2018. Brolucizumab has proven to be more effective than Aflibecert over […]
The new therapy for diabetic maculopathy was finally approved in Italy (January 2017) as a class H therapy, i.e. paid for by the national health service. It is a cortisone-based drug (fluocinolone) that is administered by intravitreal injection. It has proven effective in the treatment of diabetes-related maculopathy (Diabetic Macular Edema). Unlike other drugs used […]
What is Yellow Laser The Micropulsed Yellow Laser is a new treatment modality for some types of maculopathy such as Central Serous Corio Retinopathy (CRSC) , diabetic retinopathy with macular edema , retinal vein thrombosis with macular edema. Laser for the treatment of maculopathy has been used for several years. The traditional laser causes heating […]
